Literature DB >> 15788707

Embryonic stem cells: prospects for developmental biology and cell therapy.

Anna M Wobus1, Kenneth R Boheler.   

Abstract

Stem cells represent natural units of embryonic development and tissue regeneration. Embryonic stem (ES) cells, in particular, possess a nearly unlimited self-renewal capacity and developmental potential to differentiate into virtually any cell type of an organism. Mouse ES cells, which are established as permanent cell lines from early embryos, can be regarded as a versatile biological system that has led to major advances in cell and developmental biology. Human ES cell lines, which have recently been derived, may additionally serve as an unlimited source of cells for regenerative medicine. Before therapeutic applications can be realized, important problems must be resolved. Ethical issues surround the derivation of human ES cells from in vitro fertilized blastocysts. Current techniques for directed differentiation into somatic cell populations remain inefficient and yield heterogeneous cell populations. Transplanted ES cell progeny may not function normally in organs, might retain tumorigenic potential, and could be rejected immunologically. The number of human ES cell lines available for research may also be insufficient to adequately determine their therapeutic potential. Recent molecular and cellular advances with mouse ES cells, however, portend the successful use of these cells in therapeutics. This review therefore focuses both on mouse and human ES cells with respect to in vitro propagation and differentiation as well as their use in basic cell and developmental biology and toxicology and presents prospects for human ES cells in tissue regeneration and transplantation.

Entities:  

Mesh:

Year:  2005        PMID: 15788707     DOI: 10.1152/physrev.00054.2003

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  180 in total

Review 1.  Pluripotency of human embryonic and induced pluripotent stem cells for cardiac and vascular regeneration.

Authors:  Kenneth R Boheler
Journal:  Thromb Haemost       Date:  2010-05-10       Impact factor: 5.249

2.  A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells.

Authors:  Rebekah L Gundry; Daniel R Riordon; Yelena Tarasova; Sandra Chuppa; Subarna Bhattacharya; Ondrej Juhasz; Olena Wiedemeier; Samuel Milanovich; Fallon K Noto; Irina Tchernyshyov; Kimberly Raginski; Damaris Bausch-Fluck; Hyun-Jin Tae; Shannon Marshall; Stephen A Duncan; Bernd Wollscheid; Robert P Wersto; Sridhar Rao; Jennifer E Van Eyk; Kenneth R Boheler
Journal:  Mol Cell Proteomics       Date:  2012-04-06       Impact factor: 5.911

3.  The effect of topography on differentiation fates of matrigel-coated mouse embryonic stem cells cultured on PLGA nanofibrous scaffolds.

Authors:  Mohammad Massumi; Mozhgan Abasi; Hamideh Babaloo; Panieh Terraf; Mojtaba Safi; Mahdi Saeed; Jalal Barzin; Mojgan Zandi; Masoud Soleimani
Journal:  Tissue Eng Part A       Date:  2011-12-14       Impact factor: 3.845

4.  Rapid fabrication of a microdevice with concave microwells and its application in embryoid body formation.

Authors:  Youchun Xu; Fengbo Xie; Tian Qiu; Lan Xie; Wanli Xing; Jing Cheng
Journal:  Biomicrofluidics       Date:  2012-02-24       Impact factor: 2.800

5.  Large scale phosphoproteome profiles comprehensive features of mouse embryonic stem cells.

Authors:  Qing-Run Li; Xiao-Bin Xing; Tao-Tao Chen; Rong-Xia Li; Jie Dai; Quan-Hu Sheng; Shun-Mei Xin; Li-Li Zhu; Ying Jin; Gang Pei; Jiu-Hong Kang; Yi-Xue Li; Rong Zeng
Journal:  Mol Cell Proteomics       Date:  2010-12-13       Impact factor: 5.911

6.  Directing human embryonic stem cell differentiation by non-viral delivery of siRNA in 3D culture.

Authors:  Janet Zoldan; Abigail K R Lytton-Jean; Emmanouil D Karagiannis; Kaila Deiorio-Haggar; Leon M Bellan; Robert Langer; Daniel G Anderson
Journal:  Biomaterials       Date:  2011-08-11       Impact factor: 12.479

Review 7.  Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology.

Authors:  Rebekah L Gundry; Paul W Burridge; Kenneth R Boheler
Journal:  Proteomics       Date:  2011-09-08       Impact factor: 3.984

8.  Identification of embryonic stem cell activities in an embryonic cell line derived from marine medaka (Oryzias dancena).

Authors:  Dongwook Lee; Jun Hyung Ryu; Seung Tae Lee; Yoon Kwon Nam; Dong Soo Kim; Seung Pyo Gong
Journal:  Fish Physiol Biochem       Date:  2015-08-04       Impact factor: 2.794

Review 9.  Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.

Authors:  Luqia Hou; Joseph J Kim; Y Joseph Woo; Ngan F Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-12-18       Impact factor: 4.733

10.  Mouse embryonic stem cells have underdeveloped antiviral mechanisms that can be exploited for the development of mRNA-mediated gene expression strategy.

Authors:  Ruoxing Wang; Chengwen Teng; Joseph Spangler; Jundi Wang; Faqing Huang; Yan-Lin Guo
Journal:  Stem Cells Dev       Date:  2013-12-20       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.